Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to characterize the safety/tolerability of pazopanib and
lapatinib when administered in combination with enzyme-inducing anticonvulsants in patients
with recurrent Grade III or IV malignant gliomas.